Genetic Variants in Melatonin Receptor Linked to Diabetes

This article originally appeared here.
Genetic Variants in Melatonin Receptor Linked to Diabetes
Genetic Variants in Melatonin Receptor Linked to Diabetes

(HealthDay News) -- Rare variants of the melatonin receptor 1B (MTNR1B) gene are associated with a higher risk of type 2 diabetes, according to a study published online January 29 in Nature Genetics.

Noting that previous genome-wide association studies had showed that common noncoding variants of MTNR1B were associated with an increased risk of type 2 diabetes, Amélie Bonnefond, from the Lille Pasteur Institute in France, and colleagues performed large-scale exon resequencing of the gene in 7,632 Europeans, of whom 2,186 had type 2 diabetes.

The researchers identified 40 non-synonymous variants associated with type 2 diabetes, of which 36 were very rare and significantly associated with increased diabetes risk (odds ratio [OR], 3.31). Fourteen of the variants were nonfunctional and rare, and four were very rare, resulting in complete loss-of-function. Among the very rare variants, those with partial or total loss-of-function were significantly associated with type 2 diabetes (OR, 5.67), whereas neutral variants were not associated with type 2 diabetes risk. The association of the four very rare, complete loss-of-function variants was verified in an independent group of 11,854 individuals (OR, 3.88).

"This study establishes a firm functional link between MTNR1B and type 2 diabetes risk," Bonnefond and colleagues conclude.

One of the study authors is an employee of Prognomix.

Abstract
Full Text (subscription or payment may be required)